Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingwen granules versus oseltamivir in children with influenza
ChiCTR1900028390Phase 4Not yet recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lianhua Qingwen and oseltamivir in influenza (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Clinical recovery time. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
Lianhua Qingwenoseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR1900028390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028390.